Research professionals are encouraged to use the contact information on the "Our Team" page of this site to get in touch with members of the NCPC team, or email us at ncpc@northwestern.edu for more information about chemoprevention trials.
Information regarding previous publications and findings can be found in the "Completed Trials" section of our website.
Are you planning to have breast surgery?
Many women hesitate to take breast cancer prevention medication for fear of side effects. We are trying to reduce the side effects of these medications by using a medicated gel, applied to the breast skin. Currently, two of our studies are looking at the use of medicated gel as possible breast cancer prevention methods. Applying medicated gel to the breast skin in the weeks leading up to your breast surgery will not treat your current condition and will not interfere with your surgery, but will help us find out if this may be a safe and effective method for breast cancer prevention.
Testing an Active Form of Tamoxifen Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Principal Investigator: Seema Khan, M.D.
Northwestern University
This study is no longer accepting patients. To learn more about this study, please visit
Additional Resources
DCIS Fact Sheet
Preguntas Frecuentes Sobre El DCIS De Mama
Study Brochure
Folleto
Endoxifen Gel vs. Placebo Gel in Women Undergoing Breast Surgery
Principal Investigator: Seema Khan, M.D.
Northwestern University
This is a study is no longer accepting patients. To learn more about this study, please visit
38
Additional Resources
Study Brochure